Welcome to Cancer Gene Therapy
Cancer Gene Therapy is the essential gene therapy resource for cancer researchers and clinicians, keeping readers up to date with the latest developments in gene therapy for cancer. It publishes original laboratory and clinical research papers, case reports and review articles on topics including RNAi approaches, drug resistance, hematopoietic gene transfer, homologous recombination, ribozyme technology, antisense technology, tumor immunotherapy and tumor suppressors,translational research, cancer therapy, gene delivery systems (viral and non-viral), anti-gene therapy (antisense, siRNA & ribozymes), apoptosis; mechanisms and therapies, vaccine development, immunology and immunotherapy, DNA synthesis and repair.
*** Announcing Cancer Gene Therapy Open ***
Cancer Gene Therapy now offers authors the option to publish their articles with immediate open access upon publication. Open access articles will also be deposited on PubMed Central at the time of publication and will be freely available immediately. Find out more from the press release or our FAQs page.
******
Free online issue
Volume 16, No 12
December 2009
ISSN: 0929-1903
EISSN: 1476-5500
2008 impact factor 3.005*
24/82 Medicine, Research & Experimental
36/144 Biotechnology & Applied Microbiology
60/141 Oncology
59/138 Genetics & Heredity
Editors:
Robert E Sobol
Kevin J Scanlon
*2008 Journal Citation Reports, Thomson Reuters, 2009
FEATURED ARTICLES
ORIGINAL ARTICLE
Dynamics of tumor virotherapy with measles viruses FREEORIGINAL ARTICLE
Conditional IL-12 gene therapy FREEORIGINAL ARTICLE
PEI-WT1 RNAi inhibits lung tumor growth FREENEWS
From humble beginnings as an obscure phenomenon in plants, RNA interference (RNAi) has evolved into an area of significant impact in numerous fields. The newly launched RNAi Gateway provides a convenient portal into publications relevant to every aspect of RNAi from journals throughout the Nature Publishing Group.
The most comprehensive analysis of cutting-edge research into p53 can be found in a new review published in Cancer Gene Therapy. The fundamental molecule p53 is involved in almost all cancers and the extensive integration of knowledge in this review highlights possible applications of the research that will be of direct benefit to cancer patients.
-
Research and Reviews
Latest research highlights and reviews from the NPG family of journals
